ArunA Bio to Provide Corporate Update and Participate on a Panel at the 2019 BIO International Convention

Staff Report From Athens CEO

Friday, May 31st, 2019

ArunA Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, announced that Dr. Mark A. Sirgo, Chief Executive Officer, will lead a corporate presentation at the 2019 BIO International Convention occurring June 3-6, 2019 in Philadelphia, PA. Dr. Sirgo will provide an update on the company’s emerging pipeline and proprietary neural exosome drug delivery capabilities.

In addition, Dr. Steven Stice, Co-Founder and Chief Scientific Officer, will participate on a panel entitled “Harnessing the Potential of Exosomes”. The panel will explore the full potential of exosomes, and Dr. Stice will discuss the use of exosomes as both a therapeutic and a drug delivery vehicle.

Details of the Corporate Presentation:

Date: Tuesday, June 4, 2019

Time: 11:15-11:30 am ET

Location: Company Presentation Theater 2, Level 200, Philadelphia Convention Center

Details of the Panel:

Title:Harnessing the Potential of Exosomes

Date: Tuesday, June 4, 2019

Time: 3:15-4:15 pm ET

Location: 105AB, Level 100, Philadelphia Convention Center